Beyond Meat, Inc. (BYND) - Due Diligence

hourglass

Caricamento company...

Sto preparando dati, stili e contenuti aggiornati della DD.

18RiskyDD: Jun 25, 2026Analyst: 20

paidPrice

$0.69

domainMkt cap

$358.63M

pie_chartShares

519.8M

candlestick_chart52W

$0.50-$7.69

trending_downShort interest

31.1%

HIGHNASDAQ Global SelectPlant-based food & alternative protein600 employeesFounded 2009

Verdict: Unfavorable — Distressed / Going Concern profile

Iconic plant-based brand collapsed into structural distress: stock −99.7% from 2021 peak, secular demand decay (revenue $275M FY25 from $465M FY21), Q1 2026 sales −15% YoY, deeply negative shareholder equity (−$784M FY25 pre-restructuring, −$21M post). Cash $206M offset by $412M debt + ~$145M annualized operating burn. Nasdaq delisting risk: compliance window expires Aug 31, 2026, reverse split already shareholder-approved. Material weakness in internal controls + delayed 10-K filing + $39M litigation accrual. Equity is essentially an out-of-the-money option on category recovery + balance-sheet resolution. Prob-weighted FV $0.59 vs spot $0.69 = base downside −14.5%. Asymmetry insufficient to compensate for binary equity-wipe risk.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-06-25

Beyond Meat, Inc. (BYND)

Plant-based food · NASDAQ Global Select · El Segundo, CA

"Distressed equity option on category survival + balance-sheet workout; small chance of large outcomes either way."

Going concern Delisting risk Material weakness Revenue −15% YoY Short interest 31%

Fin. strength

/20 pts

EBITDA/FCF

/15 pts

Debt/leverage

/15 pts

Stage/business

/15 pts

Catalysts

/10 pts

Reg. risk

/8 pts

Risk/reward

/7 pts

Management

/5 pts

Sector/macro

/3 pts

Compliance

/2 pts

💡 Fair Value Estimate — Probability-weighted SotP (going-concern restructuring scenarios)

Fair value base case

USD 0.59

Range: USD 0.05-USD 1.75

Current price ~USD 0.69

Base upside/downside: -14%

Methodology: Probability-weighted SotP for distressed equity. Prob-weighted FV $0.59 vs spot $0.69 → base downside −14.5% ((0.59 − 0.69) / 0.69). The 45% bear-case weighting reflects the structural-insolvency reality (stockholders deficit even after $549M debt-restructuring gain). Cross-check: at $0.69 spot, market implies ~30% probability of bull-case outcome — which seems generous given Q1 revenue continued to fall 15%. Asymmetry test: bull gain +160% vs bear loss −85% with the bear having higher probability → expected value is negative. The setup is sized for a SHORT, not a long. ⚠️ Not investment advice.

Component	Assumption	USD/share
Brand & revenue value (base scenario)	FY26E revenue $245M × 0.30x EV/Rev = $73.5M EV / 575M dil. shares (post-conversion)	+0.13
Cash floor (residual after burn)	($206M Q1 cash − $135M FY26 burn run-rate) ≈ $71M / 575M shares	+0.12
Convertible debt (2027 + 2030 stack)	$412M total debt − $206M cash = −$206M net debt / 575M shares	−0.36
Litigation reserve	$39M accrued litigation provision / 575M shares	−0.07
Brand IP & distribution franchise option	10% prob × $200M strategic acquisition value = $20M / 575M shares	+0.03
FV base case (point estimate)	Sum of rows above (mathematical: 0.13 + 0.12 − 0.36 − 0.07 + 0.03 = −0.15; floored at zero recovery)	≈ $0.10

Bull

$1.50–2.00

Probability: 15%

Reverse split executes (e.g., 1-for-10), Nasdaq listing maintained, revenue stabilizes H2 2026 (foodservice partnerships, China re-entry, GLP-1 weight-loss tailwind for plant protein). Strategic buyer (Tyson, JBS, Conagra) acquires for brand IP at $1-2B EV. Equity recovers to $1.50-2.00.

Base

USD 0.50-USD 0.68

Probability: 40%

Reverse split, listing maintained, revenue continues declining mid-single-digits, more convertible-to-equity conversions, 2027 notes refinanced at distressed terms. Stock muddles in $0.50-0.80 post-split-equivalent for 12-18 months.

Bear

$0.05–0.20

Probability: 45%

Cash runway insufficient for 2027 convertible refi; Chapter 11 restructuring or out-of-court exchange wipes equity to near-zero. TTCF precedent applies. Material weakness uncovers further accounting issues. Litigation costs escalate.

Methodology: Methodology: Probability-weighted SotP for distressed equity. Prob-weighted FV $0.59 vs spot $0.69 → base downside −14.5% ((0.59 − 0.69) / 0.69). The 45% bear-case weighting reflects the structural-insolvency reality (stockholders deficit even after $549M debt-restructuring gain). Cross-check: at $0.69 spot, market implies ~30% probability of bull-case outcome — which seems generous given Q1 revenue continued to fall 15%. Asymmetry test: bull gain +160% vs bear loss −85% with the bear having higher probability → expected value is negative. The setup is sized for a SHORT, not a long. ⚠️ Not investment advice. Not investment advice.

warning

🚨 GOING CONCERN / DELISTING RISK / MATERIAL WEAKNESS

Three simultaneous red flags: (1) Nasdaq notice received Mar 4, 2026 for sub-$1.00 close 30 days — compliance window until Aug 31, 2026, with reverse-split authority already in hand from Nov 19, 2025 shareholder vote. (2) Stockholders deficit −$21.1M as of Q1 (post massive $548.7M non-cash debt-restructuring gain that lifted FY25 equity from −$784M); without that one-time gain the balance sheet would still be deeply insolvent. (3) Material weakness in internal controls disclosed: FY25 10-K filing was delayed, inventory and COGS accounting errors required correction. Cumulative implication: equity-holder recovery in a restructuring scenario could be ~$0.00; convertible noteholders sit ahead in any priority waterfall.

⚠️ Methodology note: Distressed / going concern profile dictates probability-weighted scenario valuation, NOT a single-point EV/Revenue or DCF. Bear scenarios with material equity-wipe probability dominate the expected value calculation. Cash floor adjusted for residual burn through resolution. Multiples used only as sanity checks against the recovery-scenario base.

📊 Capital Structure · Short Interest · Buyback & Dilution

🔴 Short Interest

31.1%

142.1M shares short on ~457M float (May 2026 report). Days to cover: 3.96. Very high — squeeze risk on positive news, but the structural short thesis is well-known.

🔴 Share dilution (1Y)

+685%

From ~66M (FY24) to ~520M post-Q1 conversion. $62.6M of 2030 converts → 52.1M new shares (Apr 2026). Chronic dilution structurally embedded via convertible stack.

🔴 Buyback

Zero buyback. Reverse split pending (1-for-? not yet announced). Capital priority is survival, not capital return.

Short Interest — context

BYND — 31.1%

31.1%

Short interest in the >25% "very high" zone confirms market consensus on the distress thesis. Days to cover 3.96 implies a squeeze IS possible on positive news (April 2026 saw a relief rally on 10-K filing). Insider activity: no purchases in last 3 months; insider sales totaling $0.3M over 12 months. Institutional exodus: 51% reduction in institutional ownership cited in May 2026 commentary. Founder/CEO Ethan Brown remains in charge but execution credibility is severely damaged.

$Financial analysis — FY 2025 + Q1 2026

Revenue FY25

$275.5M

−15.6% YoY (vs $326M FY24, $465M FY21 peak)

Q1 2026 Revenue

$58.2M

−15.2% YoY (Q2 guide $60-65M)

Cash Q1 26

$205.8M

Operating burn ~$11M/qtr; capex add'l

Net debt

$205.8M

$411.6M total debt − $205.8M cash

Item	FY2023	FY2024	FY2025	Q1 2026	FY2026 outlook
Revenue ($M)	343.4	326.5	275.5	58.2	~$240-250M
Gross margin %	−24%	−5%	2.8%	3.4%	~5-8%
Adj EBITDA ($M)	−267	−151	−179	−24	−90 to −110
Net income ($M)	−338	−169	+219*	−28.5	−100 to −150
Cash EOP ($M)	205.7	222.4	210.7	205.8	~$50-80M
Total debt ($M)	1,143	1,143	457	411.6	~$300M post-conversions
Shareholders equity ($M)	−457	−622	−784	−21	Volatile, near zero

*FY25 net income $219M includes a $548.7M non-cash gain on debt restructuring. Underlying operating performance was deeply negative (loss from operations −$333.6M including inventory write-downs, China exit costs, asset write-downs, and $38.9M litigation accrual).

Quarterly dynamics — last 5 quarters
Metric	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue ($M)	68.7	75.1	70.5	61.2	58.2
Gross margin %	−2%	5%	7%	1%	3.4%
Net loss ($M)	−52.2	−34.8	−26.6	+332*	−28.5
Cash EOP ($M)	199.6	173.4	180.5	210.7	205.8

*Q4 2025 net income includes the bulk of the $548.7M non-cash debt-restructuring gain.

Financial position and sustainability

Cash runway (mo, gross burn)

~17 mo

Revenue trajectory (YoY %)

−15%

Gross margin recovery

3.4%

Nasdaq compliance buffer ($0.69 vs $1.00)

$0.31 gap

account_tree

Business model — Plant-based meat alternatives, brand under structural pressure

Iconic brand fighting a category decline

Beyond Meat manufactures and sells plant-based substitutes for beef, pork and poultry under the Beyond brand, sold through US/EU retail (~50% of sales) and foodservice (~50%, including QSR partnerships with McDonald's, KFC, Pizza Hut, Panda Express). The category boomed 2018-2021 on health/sustainability narratives, then collapsed: US plant-based meat retail sales declined consecutively 2022-2025 as consumers concluded products are expensive, ultra-processed, and unsatisfying. Beyond exited China (FY25 write-down), tried "Beyond IV" recipe reformulation, and shifted toward higher-margin foodservice partnerships. Q1 2026 GM turned positive (3.4%) on cost cuts, but revenue trajectory remains negative. The fundamental question is whether the category stabilizes at a smaller-but-viable size or continues toward irrelevance.

US Retail ~$120M FY26E (~49% rev) 🔴 declining Walmart, Kroger, Target, Whole Foods shelf presence. Category declining double-digits. Beyond IV reformulation (2024) failed to revive growth. Price gap vs animal meat unchanged. US Foodservice ~$80M FY26E (~33% rev) 🟡 mixed Partnerships with QSR (McDonald's McPlant in some markets, Pizza Hut, Panda Express). Higher GM but unit volumes tied to LTO promotion cycles. Stable but not growing. International (excl. China) ~$45M FY26E (~18% rev) 🔴 contracting EU retail + foodservice. Distribution in 80+ countries. Lidl, Tesco, Carrefour. Category dynamics similar to US. China exited in FY25 with $20M+ write-down.

gavel

Legal, regulatory and risk analysis

Equity-wipe risk (going concern)

Critical

Stockholders deficit −$21M Q1 (after $549M one-time gain). 2027 convertible notes need refinancing; if equity-linked, further massive dilution; if cash, requires raise the company cannot afford. Chapter 11 / out-of-court restructuring real probability.

Nasdaq delisting risk

High

Compliance window expires Aug 31, 2026. Stock at $0.69 vs $1.00 minimum. Reverse split (e.g., 1-for-10) will be executed but solves listing not fundamentals; post-split price would be ~$6.90 with same business mess.

Material weakness in controls

High

FY25 10-K filing delayed due to inventory/COGS errors. Restated figures. Audit committee disclosed material weakness. Auditor going-concern flag implicit. Further restatements possible.

Category demand decline

High

US plant-based meat retail dollar sales declined consecutively for 4+ years. Consumer perception turned (ultra-processed, expensive). GLP-1 weight-loss drugs reduce protein-substitution use case. No clear path to category re-acceleration.

Litigation accruals

Moderate

$38.9M litigation accrual in FY25. Class actions on accounting / disclosure pending. Quantification incomplete; could expand on adverse outcomes.

Cash on balance sheet

Moderate

$206M cash provides ~17 months runway at current burn — meaningful but not unlimited. Q1 26 burn was only $5M (improved working capital), but unsustainable without revenue stabilization.

Strategic acquirer optionality

Positive

Brand recognition + distribution footprint + IP could attract Tyson, JBS, Conagra, or PE buyer at $0.50-1.00B EV. Low-probability but real source of upside. Higher in distressed scenarios with cleaner balance sheet post-restructuring.

Gross margin recovery in Q1

Positive

GM turned positive (3.4% Q1 vs −2% prior year). Cost-cut and product mix shifts working. Not enough to fix the business but a directional positive that delays default risk.

article

SWOT analysis

Strengths

+Iconic brand recognition — still the #1 named plant-based brand
+Distribution footprint in 80+ countries / major US retailers
+Foodservice QSR partnerships (McDonald's McPlant, Pizza Hut, etc.)
+$206M cash provides multi-quarter buffer
+Q1 26 GM turned positive — first time in years

Weaknesses

−Revenue −41% from FY21 peak; trajectory still negative
−Stockholders deficit; $412M debt vs $206M cash
−Material weakness in internal controls (10-K delayed)
−Adjusted EBITDA −$179M FY25
−Premium pricing vs animal meat = structural demand drag

Opportunities

→Strategic acquirer (Tyson, JBS, Conagra) for brand IP
→Reverse split removes delisting cloud near-term
→Foodservice expansion if category stabilizes
→Short squeeze potential on any positive surprise
→Whole-foods / clean-label reformulation could re-attract consumers

Threats

!2027 convertible refi: forced restructuring scenario
!Category continues to shrink; brand becomes orphan asset
!Further accounting restatements / SEC action
!GLP-1 drugs reduce meat-substitute demand
!Cheaper private-label / store-brand plant-meat erodes share

article

Summary by assessment area

🔴 Financial — Critical

Stockholders deficit even post $549M restructuring gain
Cash $206M, burn $145M/yr operating
$412M debt; 2027 converts need refi
Material weakness in controls

🔴 Business — Structural decline

Revenue −15% YoY 5 consecutive years
Plant-based category in 4-yr decline
China exit, retail share losses
QSR partnerships unable to offset retail

🔴 Risk/Reward — Unfavorable

Prob-weighted FV $0.59 vs spot $0.69 = base downside −14.5%
Bull/Bear: +160% vs −85% with bear 45% prob
Expected value negative
Setup is short-skewed, not long

{ "verdict_label": {"it": "Sfavorevole — Going concern", "en": "Unfavorable — Going concern"}, "verdict_text": {"it": "Brand iconico in distress strutturale: revenue -41% dal picco, equity quasi azzerata, delisting risk, dipende dal refi del 2027. FV ponderato $0.59 vs prezzo $0.69 → setup short, non long.", "en": "Iconic brand in structural distress: revenue -41% from peak, equity near-zero, delisting risk, depends on 2027 refi. Prob-weighted FV $0.59 vs $0.69 spot → setup is short, not long."}, "bull_points": [ {"it": "Cash $206M offre runway 17 mesi; gross margin Q1 turnata positiva al 3.4%.", "en": "$206M cash provides 17-month runway; Q1 GM turned positive at 3.4%."}, {"it": "Brand iconico + distribuzione globale = possibile target acquisitivo (Tyson/JBS/Conagra) per $1-2B EV.", "en": "Iconic brand + global distribution = potential acquisition target (Tyson/JBS/Conagra) at $1-2B EV."}, {"it": "Short interest 31% + reverse split imminente: squeeze risk su qualsiasi sorpresa positiva.", "en": "Short interest 31% + imminent reverse split: squeeze risk on any positive surprise."} ], "bear_points": [ {"it": "Revenue −15% YoY 5 anni consecutivi, categoria plant-based in declino strutturale.", "en": "Revenue −15% YoY for 5 consecutive years, plant-based category in structural decline."}, {"it": "Stockholders deficit anche dopo $549M gain non-cash; $412M debt vs $206M cash.", "en": "Stockholders deficit even post $549M non-cash gain; $412M debt vs $206M cash."}, {"it": "Material weakness in controlli interni, 10-K ritardato, $39M litigation accrual.", "en": "Material weakness in internal controls, delayed 10-K, $39M litigation accrual."} ], "risks": [ {"it": "Refi del 2027 convertible: ristrutturazione forzata azzera l'equity (45% probabilità).", "en": "2027 convertible refi: forced restructuring wipes equity (45% probability)."}, {"it": "Nasdaq delisting se reverse split non esegue entro 31 ago 2026.", "en": "Nasdaq delisting if reverse split not executed by Aug 31, 2026."}, {"it": "GLP-1 e private label erodono ulteriormente la categoria di riferimento.", "en": "GLP-1 and private label further erode the reference category."} ] }

Sources & Disclaimer

Sources: Beyond Meat Q1 2026 earnings release (May 7, 2026), FY2025 annual report & 10-K (filed Apr 9, 2026), Q1 2026 10-Q (SEC EDGAR), StockTitan Q1 2026 coverage, The Motley Fool Q1 2026 earnings transcript, Yahoo Finance / Robinhood quote (close $0.69 Jun 24, 2026), TipRanks Nasdaq delisting risk article, AInvest "51% Institutional Exodus" (May 26, 2026), MarketBeat short interest (31.1%, May 2026), Public.com analyst consensus ($0.66, 5 analysts, Jun 2026), MacroTrends shares outstanding history. Market data — last verified close 2026-06-24: BYND $0.69 (verified via 2 sources: Robinhood/CNBC + Yahoo/Investing.com; sanity check $0.69 × 519.8M shares = $358.7M vs declared mc $358.63M ✅; 52W range $0.50-$7.69 ✅). Market cap $358.63M, ~519.8M shares outstanding (post Q1 conversion of $62.6M 2030 notes into 52.1M shares + 3.9M anti-dilution RSU grants). Short interest 31.1% (142.1M shares short on ~457M float). Cash Q1 26 EOQ $205.8M. Total debt $411.6M. FY25 revenue $275.5M (−15.6% YoY); FY25 adjusted EBITDA −$179.3M; FY25 net income +$219M (includes $548.7M non-cash debt-restructuring gain). Stockholders deficit Q1 26: −$21.1M. Nasdaq delisting notice received Mar 4, 2026; compliance deadline Aug 31, 2026. Reverse split authority granted by shareholders Nov 19, 2025. Material weakness in internal controls disclosed in FY25 10-K. ⚠️ This document is for informational purposes only and does not constitute financial or investment advice.